|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.11 USD | -1.96% |
|
-0.56% | +19.23% |
| May. 18 | Declaration of Voting Results by CVS Health Corporation | CI |
| May. 15 | Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health | RE |
Business description: CVS Health Corporation
- medical benefits management (40,2%);
- medical insurance plan management services (30,3%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (29.4%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2025, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- other (0.1%).
Number of employees: 259,500
Sales by Activity: CVS Health Corporation
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Health Services | 153B | 169B | 187B | 173B | 190B |
Pharmacy & Consumer Wellness | 100B | 107B | 117B | 124B | 139B |
Health Care Benefits | 81.6B | 90.93B | 105B | 129B | 142B |
Corporate/Other | 125M | 124M | 57M | 56M | 53M |
Intersegment Eliminations | -43.92B | -45.3B | -51.93B | -56.41B | -71.56B |
Geographical breakdown of sales: CVS Health Corporation
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 291B | 322B | 357B | 371B | 400B |
Executive Committee: CVS Health Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
David Falkowski
CMP | Compliance Officer | - | 2015-06-30 |
Madi Rajulapalli
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Tech/Sci/R&D Officer | 62 | 2025-05-18 |
Composition of the Board of Directors: CVS Health Corporation
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 | |
Fernando Aguirre
BRD | Director/Board Member | 68 | 2018-11-27 |
Jeffrey Balser
BRD | Director/Board Member | 64 | 2022-09-11 |
J. Joyner
CHM | Chairman | 62 | 2025-12-31 |
J. Kirby
BRD | Director/Board Member | 58 | 2023-09-30 |
Michael Mahoney
BRD | Director/Board Member | 61 | 2023-10-31 |
Leslie Norwalk
BRD | Director/Board Member | 60 | 2024-11-16 |
Lawrence Robbins
BRD | Director/Board Member | 56 | 2024-11-16 |
Holdings: CVS Health Corporation
| Name | Equities | % | Valuation |
|---|---|---|---|
SPDR S&P 500 ETF TRUST 0.01% | 87,578 | 0.01% | 63 M $ |
| 182,800 | 0.12% | 22 M $ | |
| 233,100 | 0.08% | 19 M $ | |
| 294,400 | 0.07% | 15 M $ | |
| 149,700 | 0.01% | 15 M $ | |
| 348,100 | 0.05% | 13 M $ | |
| 107,000 | 0.07% | 10 M $ | |
| 85,000 | 0.01% | 5 M $ | |
| 98,795 | 0.02% | 5 M $ | |
| 98,500 | 0.01% | 5 M $ |
Company details: CVS Health Corporation
Group companies: CVS Health Corporation
| Name | Category and Sector |
|---|---|
Aetna Better Health, Inc. (New York)
 Aetna Better Health, Inc. (New York) Medical/Nursing ServicesHealth Services Provides health care services |
Medical/Nursing Services
|
Aetna Better Health, Inc. (New York)
Aetna Better Health, Inc. (New York) Medical/Nursing ServicesHealth Services Provides health care services |
Medical/Nursing Services
|
Aetna Health & Life Insurance Co.
 Aetna Health & Life Insurance Co. Multi-Line InsuranceFinance Provides life insurance services |
Multi-Line Insurance
|
Aetna Health & Life Insurance Co.
Aetna Health & Life Insurance Co. Multi-Line InsuranceFinance Provides life insurance services |
Multi-Line Insurance
|
Texas Health + Aetna Health Plan, Inc. |
Other Healthcare Facilities & Services
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.82% | -0.56% | +50.72% | +36.38% | 122B | |
| -4.15% | -5.25% | +5.23% | +44.14% | 93.79B | |
| +1.12% | +0.33% | -8.47% | +44.23% | 25.7B | |
| +0.42% | +0.16% | +6.94% | +44.86% | 21.01B | |
| -0.72% | -1.57% | +1.40% | +16.83% | 20.96B | |
| -2.09% | -4.10% | -20.81% | -24.21% | 20.52B | |
| -0.74% | -2.37% | +14.32% | +162.40% | 16.58B | |
| -2.07% | -5.34% | -6.35% | +17.85% | 15.25B | |
| -2.42% | -2.91% | +34.31% | +94.05% | 12.81B | |
| +0.58% | +1.81% | -25.78% | -11.31% | 11.92B | |
| Average | -1.36% | -0.06% | +5.15% | +42.52% | 36.1B | |
| Weighted average by Cap. | -2.06% | +0.91% | +18.02% | +40.35% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
- Company CVS Health Corporation
Select your edition
All financial news and data tailored to specific country editions
